French Biotech Company Adipopharma Secures Series A Funding For Groundbreaking Diabetes Drug
Round Type
Series A
StrasbourgBiotechnologyHealth CareMedicalDescription
AdipoPharma, a French biotech company developing a novel and promising type 2 diabetes drug, announced today that it has successfully secured Series A funding. It expects to enter clinical trials later this year with a drug that represents the first, therapeutic breakthrough for type 2 diabetes treatment in more than a decade.
Quick answer
AdipoPharma raised an undisclosed amount in a Series A round, dated January 23, 2023. AdipoPharma is based in Strasbourg, Grand Est, France.
- How much did AdipoPharma raise?
- AdipoPharma raised an undisclosed amount in a Series A round on January 23, 2023.
- What does AdipoPharma do?
- AdipoPharma SAS is committed to understanding the role of the adipocyte cells in diabetes via their unique effect on lipid biosynthesis and management of whole-body lipid homeostasis.
- Where is AdipoPharma based and how big is it?
- AdipoPharma is based in Strasbourg, Grand Est, France.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as AdipoPharma that raised within 45 days of this round, from Fundz verified event records.
- Wave Life raised $6M on March 7, 2023.
- U.S. Renal Care raised $1.4M (Seed) on March 7, 2023.
- U.S. Renal Care raised $3.2M (Seed) on March 6, 2023.
- Autonomix Medical raised $675K (Seed) on March 6, 2023.
- SigTuple raised $4.5M (Seed) on March 1, 2023.
- Transcend Therapeutics raised an undisclosed amount (Series A) on February 23, 2023.
Who to call at AdipoPharma, and when
A new round usually means AdipoPharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AdipoPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AdipoPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AdipoPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AdipoPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Funding Insights
What this usually meansAdipoPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.